𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic gastrointestinal cancer

✍ Scribed by Carlsson, Göran; Graf, Wilhelm; Gustavsson, Bengt G.; Glimelius, Bengt; Påhlman, Lars; Spears, Paul C.

Book ID
122822350
Publisher
Elsevier Science
Year
1990
Weight
337 KB
Volume
26
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adriamycin, CCNU, and 5-fluorouracil in
Adriamycin, CCNU, and 5-fluorouracil in patients with advanced gastrointestinal cancer
✍ Bjöurn J. Cedermark; Peter Cunven; Gary Hammarberg 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

## Abstract Forty‐one patients with measurable advanced gastrointestinal malignancy were treated with a combination of Adriamycin (doxorubicin), 5‐FU (5‐fluorouracil), and CCNU (1‐(2‐chloroethyl)‐3‐cyclohexyl‐1‐nitrosourea). The response to therapy was evaluated every eight weeks. In addition to st

5-fluorouracil with leucovorin in breast
5-fluorouracil with leucovorin in breast cancer
✍ Charles L. Loprinzi 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 1 views

Extensive preclinical data have demonstrated that leucovorin can modulate 5-fluorouracil (5-FU) cytotoxicity. Additionally, randomized clinical trials have shown that leucovorin increases the therapeutic index of 5-FU in patients with advanced colorectal cancer, setting a new therapeutic standard fo